1. Identification of a novel PCNT founder pathogenic variant in the Israeli Druze population.
- Author
-
Weiss K, Ekhilevitch N, Cohen L, Bratman-Morag S, Bello R, Martinez AF, Hadid Y, Shlush LI, Kurolap A, Paperna T, Mory A, Baris HN, and Muenke M
- Subjects
- Adolescent, Alleles, Cell Line, Tumor, DNA Mutational Analysis, Dwarfism diagnosis, Dwarfism genetics, Facies, Female, Fetal Growth Retardation diagnosis, Fetal Growth Retardation genetics, Genetic Testing, Humans, Israel, Male, Microcephaly diagnosis, Microcephaly genetics, Osteochondrodysplasias diagnosis, Osteochondrodysplasias genetics, Pedigree, Phenotype, Exome Sequencing, Antigens genetics, Founder Effect, Genetic Association Studies methods, Genetic Predisposition to Disease, Mutation
- Abstract
Majewski Osteodysplastic Primordial Dwarfism type II (MOPDII) is a form of dwarfism associated with severe microcephaly, characteristic skeletal findings, distinct dysmorphic features and increased risk for cerebral infarctions. The condition is caused by bi-allelic loss-of-function variants in the gene PCNT. Here we describe the identification of a novel founder pathogenic variant c.3465-1G > A observed in carriers from multiple Druze villages in Northern Israel. RNA studies show that the variant results in activation of a cryptic splice site causing a coding frameshift. The study was triggered by the diagnosis of a single child with MOPDII and emphasizes the advantages of applying next generation sequencing technologies in community genetics and the importance of establishing population-specific sequencing databases., (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF